| ID | Age | Sex | State | Date โผ | Onset Days | Vaccine | Manufacturer | Lot # | Symptoms | Narrative | ๐ | ๐ฅ | ๐ | โฟ | โ ๏ธ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2840467 | 1.5 | F | DE | 05/12/2025 |
VARCEL |
MERCK & CO. INC. |
Z003767 |
Extra dose administered
Extra dose administered
|
Patient was accidently MMR Combo along with a separate Varicella vaccine.
Patient was accidently MMR Combo along with a separate Varicella vaccine.
|
||||||
| 2840468 | 64 | F | ME | 05/12/2025 |
IPV PNC21 |
SANOFI PASTEUR MERCK & CO. INC. |
8081260 Z002626 |
Burning sensation, Erythema, Skin warm; Burning sensation, Erythema, Skin warm
Burning sensation, Erythema, Skin warm; Burning sensation, Erythema, Skin warm
|
redness, 4 inches long down her arm towards her elbow, burning sensation, hot to touch, ibuprofen an...
redness, 4 inches long down her arm towards her elbow, burning sensation, hot to touch, ibuprofen and benadryl prn
More
|
||||||
| 2840469 | 24 | M | TN | 05/12/2025 |
HEP |
DYNAVAX TECHNOLOGIES CORPORATION |
945660 |
Extra dose administered
Extra dose administered
|
PT WAS GIVEN EXTRA DOSE OF HEP B
PT WAS GIVEN EXTRA DOSE OF HEP B
|
||||||
| 2840470 | 39 | F | MA | 05/12/2025 |
PNC20 |
PFIZER\WYETH |
LX4484 |
Injection site erythema, Injection site swelling, Injection site warmth
Injection site erythema, Injection site swelling, Injection site warmth
|
Erythema, warmth, swelling at injection site, 6 cm in diameter
Erythema, warmth, swelling at injection site, 6 cm in diameter
|
||||||
| 2840471 | 31 | F | OH | 05/12/2025 |
TDAP |
GLAXOSMITHKLINE BIOLOGICALS |
EB499 |
Injection site discolouration, Injection site erythema, Injection site warmth
Injection site discolouration, Injection site erythema, Injection site warmth
|
Pt has a large area of discoloration, redness and warmth at and below injection site. Onset of sx re...
Pt has a large area of discoloration, redness and warmth at and below injection site. Onset of sx reported to have started the following day.
More
|
||||||
| 2840472 | 38 | M | SC | 05/12/2025 |
PNC21 |
MERCK & CO. INC. |
Y019157 |
Injection site erythema
Injection site erythema
|
Erythema to injection site noted two day after immunization
Erythema to injection site noted two day after immunization
|
||||||
| 2840473 | 40 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
FDP00017 |
No adverse event
No adverse event
|
The treatment was for the 2nd series of a 2-series vaccination; the outcome was uneventful, with no ...
The treatment was for the 2nd series of a 2-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
More
|
||||||
| 2840474 | 18 | M | IN | 05/12/2025 |
MENB |
PFIZER\WYETH |
LL0637 |
Headache, Injection site erythema, Injection site swelling
Headache, Injection site erythema, Injection site swelling
|
Patient developed redness and swelling at injection site. He also developed a headache that worsene...
Patient developed redness and swelling at injection site. He also developed a headache that worsened with sitting up. The headache lasted for about 3 days. A similar but more severe case of this reaction happened to his sister when she received the 2nd dose of the same vaccine.
More
|
||||||
| 2840475 | 66 | F | FL | 05/12/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
9L944 |
Mobility decreased, Pain in extremity
Mobility decreased, Pain in extremity
|
PT SAYS SHE HAS HAD ARM PAIN SINCE A COUPLE OF DAYS AFTER RECEIVING IMZ AND IT IS STILL AFFECTING HE...
PT SAYS SHE HAS HAD ARM PAIN SINCE A COUPLE OF DAYS AFTER RECEIVING IMZ AND IT IS STILL AFFECTING HER RANGE OF MOTION STILL TO THE PRESENT DAY . SHE HAS TAKE NO MEDS FOR IT ON ONLY USED "SPRAY ICE"
More
|
||||||
| 2840476 | 35 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
FDP00016 |
No adverse event
No adverse event
|
The treatment was the first two-series vaccination; the outcome was uneventful, with no symptoms or ...
The treatment was the first two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
More
|
||||||
| 2840477 | 0.75 | F | MO | 05/12/2025 |
DTAPIPVHIB |
SANOFI PASTEUR |
uk114aa |
Wrong product administered
Wrong product administered
|
Pt was administered pentacel when not needed.
Pt was administered pentacel when not needed.
|
||||||
| 2840478 | 27 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
96867 |
No adverse event
No adverse event
|
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptom...
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reactions reported.
More
|
||||||
| 2840479 | 53 | M | 05/12/2025 |
PNC20 |
PFIZER\WYETH |
|
Injection site erythema, Injection site swelling
Injection site erythema, Injection site swelling
|
Severe redness and swelling at injection site >3 days since injection
Severe redness and swelling at injection site >3 days since injection
|
|||||||
| 2840480 | 11 | F | OR | 05/12/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Incorrect dose administered
Incorrect dose administered
|
pt was given covid vaccine from age group 12-18 instead of her age gap.
pt was given covid vaccine from age group 12-18 instead of her age gap.
|
||||||
| 2840481 | 17 | F | PA | 05/12/2025 |
HEP |
DYNAVAX TECHNOLOGIES CORPORATION |
945656 |
No adverse event, Product administered to patient of inappropriate age
No adverse event, Product administered to patient of inappropriate age
|
Administered to 17-year-old. No patient issues.
Administered to 17-year-old. No patient issues.
|
||||||
| 2840483 | 10 | F | OR | 05/12/2025 |
COVID19 |
PFIZER\BIONTECH |
|
Incorrect dose administered
Incorrect dose administered
|
Patient was given wrong age group vaccine. Patient was given dose for 12 yrs - 18 yrs.
Patient was given wrong age group vaccine. Patient was given dose for 12 yrs - 18 yrs.
|
||||||
| 2840484 | 16 | F | SC | 05/12/2025 |
MNQ |
SANOFI PASTEUR |
U8256BA |
Erythema multiforme, Urticaria
Erythema multiforme, Urticaria
|
4 days after vaccine patient developed hives and suspected erythema multiforme. Hives have improved ...
4 days after vaccine patient developed hives and suspected erythema multiforme. Hives have improved but EM rash is still present.
More
|
||||||
| 2840485 | 31 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
FDP00015 |
No adverse event
No adverse event
|
The treatment was the second series of a two-series vaccination; the outcome was uneventful, with no...
The treatment was the second series of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
More
|
||||||
| 2840486 | 73 | M | FL | 05/12/2025 |
HEPA IPV TDAP YF |
GLAXOSMITHKLINE BIOLOGICALS SANOFI PASTEUR SANOFI PASTEUR SANOFI PASTEUR |
SKBV27PD PMCIA201M SKBXN575 PMCUK133AB |
Abdominal pain upper, Dehydration, Diarrhoea, Pyrexia; Abdominal pain upper, Deh...
Abdominal pain upper, Dehydration, Diarrhoea, Pyrexia; Abdominal pain upper, Dehydration, Diarrhoea, Pyrexia; Abdominal pain upper, Dehydration, Diarrhoea, Pyrexia; Abdominal pain upper, Dehydration, Diarrhoea, Pyrexia
More
|
Late friday night I got at stomach ache with bad runs and my wife called 911. I was dehydrated with ...
Late friday night I got at stomach ache with bad runs and my wife called 911. I was dehydrated with a low grade fever and they admitted me for a couple of days.
More
|
โ | |||||
| 2840487 | 65 | F | AZ | 05/12/2025 |
COVID19 COVID19 COVID19 COVID19 |
PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH PFIZER\BIONTECH |
EW0161 EW0161 EW0177 EW0177 |
Cognitive disorder, Computerised tomogram normal, Electroencephalogram normal, L...
Cognitive disorder, Computerised tomogram normal, Electroencephalogram normal, Laboratory test normal, Magnetic resonance imaging head normal; Myocardial infarction, Sjogren's syndrome, Systemic lupus erythematosus, Tremor; Cognitive disorder, Computerised tomogram normal, Electroencephalogram normal, Laboratory test normal, Magnetic resonance imaging head normal; Myocardial infarction, Sjogren's syndrome, Systemic lupus erythematosus, Tremor
More
|
2ND COVID BOOSTER PROVIDED ON JULY 1 2021, PATIENT HAD A HEART ATTACK IN AUGUST 2021 (HOSPITALIZED);...
2ND COVID BOOSTER PROVIDED ON JULY 1 2021, PATIENT HAD A HEART ATTACK IN AUGUST 2021 (HOSPITALIZED); ONSET OF TREMOR AND COGNITIVE DECLINE SEPTEMBER 2021; DX WITH LUPUS AND SJOGRENS SYNDROME 2025.
More
|
||||||
| 2840488 | 60 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
FDP00015 |
No adverse event
No adverse event
|
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptom...
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reactions reported.
More
|
||||||
| 2840489 | 31 | M | FL | 05/12/2025 |
COVID19 |
JANSSEN |
2024A21A |
Alopecia, Lichen planus, Rash, Rash erythematous
Alopecia, Lichen planus, Rash, Rash erythematous
|
Red bumps on arm and wrists consistent and hair loss consistent with Lichen Planus
Red bumps on arm and wrists consistent and hair loss consistent with Lichen Planus
|
||||||
| 2840490 | 23 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
96867 |
No adverse event
No adverse event
|
The treatment was the first two-series vaccination; the outcome was uneventful. With no symptoms or ...
The treatment was the first two-series vaccination; the outcome was uneventful. With no symptoms or signs of reactions reported.
More
|
||||||
| 2840492 | 32 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
96867 |
No adverse event
No adverse event
|
The treatment was the first two-series vaccination; the outcome was uneventful, with no symptoms or ...
The treatment was the first two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
More
|
||||||
| 2840493 | 11 | M | NM | 05/12/2025 |
HPV9 MNQ TDAP |
MERCK & CO. INC. SANOFI PASTEUR GLAXOSMITHKLINE BIOLOGICALS |
Y010466 U7996BB F4T5L |
Injection site erythema, Injection site pruritus, Injection site swelling; Injec...
Injection site erythema, Injection site pruritus, Injection site swelling; Injection site erythema, Injection site pruritus, Injection site swelling; Injection site erythema, Injection site pruritus, Injection site swelling
More
|
ITCHING TO LEFT ARM, 2 INCH DIAMETER, REDNESS SWELLING NO PAIN FOR 2 DAYS AFTER INJECTION TO SITE. ...
ITCHING TO LEFT ARM, 2 INCH DIAMETER, REDNESS SWELLING NO PAIN FOR 2 DAYS AFTER INJECTION TO SITE. FOLLOWED UP 5 DAYS LATER AND THE ISSUE WAS RESOLVED.
More
|
||||||
| 2840494 | 45 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
FDP00016 |
No adverse event
No adverse event
|
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptom...
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
More
|
||||||
| 2840495 | 13 | F | MI | 05/12/2025 |
COVID19 FLU3 TYP |
MODERNA SANOFI PASTEUR SANOFI PASTEUR |
3043000 Ut8459JA X1A271M |
Incorrect dose administered, No adverse event; Incorrect dose administered, No a...
Incorrect dose administered, No adverse event; Incorrect dose administered, No adverse event; Incorrect dose administered, No adverse event
More
|
Incorrect dose of Moderna Covid vaccine given to patient. No adverse event noticed. Patient was cont...
Incorrect dose of Moderna Covid vaccine given to patient. No adverse event noticed. Patient was contacted and told they should be revaccinated with the correct dose to ensure protection.
More
|
||||||
| 2840496 | 26 | M | WY | 05/12/2025 |
MMR |
GLAXOSMITHKLINE BIOLOGICALS |
4N222 |
Incorrect route of product administration
Incorrect route of product administration
|
Not able to contact patient, left a message on phone for a return call. Priorix is to be given SQ a...
Not able to contact patient, left a message on phone for a return call. Priorix is to be given SQ and we administered IM.
More
|
||||||
| 2840497 | 0.75 | M | 05/12/2025 |
DTAPIPVHIB |
SANOFI PASTEUR |
UK024AA |
Expired product administered
Expired product administered
|
Patient was given an expired vaccination
Patient was given an expired vaccination
|
|||||||
| 2840498 | 5 | M | ID | 05/12/2025 |
DTAPIPV HPV9 MMRV |
GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. MERCK & CO. INC. |
3RT93 Y007322 Y019465 |
Product administered to patient of inappropriate age; Product administered to pa...
Product administered to patient of inappropriate age; Product administered to patient of inappropriate age; Product administered to patient of inappropriate age
More
|
Patient was given the HPV shot that was meant for his 12 year old sister.
Patient was given the HPV shot that was meant for his 12 year old sister.
|
||||||
| 2840499 | 66 | M | CA | 05/12/2025 |
VARZOS |
GLAXOSMITHKLINE BIOLOGICALS |
3334Y |
Pruritus, Skin warm
Pruritus, Skin warm
|
Patient started developing warm, itchy spots on random parts of the body (arms, legs) after shower. ...
Patient started developing warm, itchy spots on random parts of the body (arms, legs) after shower. Lasts about an hour and then goes away. Has persisted since vaccination 3/23/25 to today, 5/12/25, though the severity of the itchiness has gradually decreased
More
|
||||||
| 2840500 | 0.33 | KS | 05/12/2025 |
RV5 |
MERCK & CO. INC. |
2003166 |
No adverse event, Product storage error
No adverse event, Product storage error
|
No adverse event; HCP calling to report AE for a vaccine that was inadvertently administered after a...
No adverse event; HCP calling to report AE for a vaccine that was inadvertently administered after a temperature excursion. ? Name of vaccines involved (including lot/exp): ROTATEQ 2003166 9/8/2025 ? Temperature: 1.5C ? Time frame; This spontaneous report was received from a registered nurse and refers to a) 4-month-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 14-APR-2025, the patient was inadvertently vaccinated with an improper stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ), (valid lot #2003166, expiration date reported as 08-SEP-2025, but upon internal validation established as 06-SEP-2025) 2 ml, once, administered by oral route as prophylaxis. The temperature excursion was reported 1.5 degree Celsius with a time frame of 50 minutes. No previous temperature excursion reported. In addition, the reported stated that the patient did not have any reactions or symptoms (no adverse event).
More
|
|||||||
| 2840501 | 45 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
96868 |
No adverse event
No adverse event
|
The treatment was the second dose of a two-series vaccination; the outcome was uneventful, with no s...
The treatment was the second dose of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
More
|
||||||
| 2840502 | 16 | F | OH | 05/12/2025 |
MENB MNQ |
NOVARTIS VACCINES AND DIAGNOSTICS SANOFI PASTEUR |
49M9N U8493AA |
Injection site erythema, Injection site oedema, Injection site pain, Injection s...
Injection site erythema, Injection site oedema, Injection site pain, Injection site swelling, Paraesthesia; Injection site erythema, Injection site oedema, Injection site pain, Injection site swelling, Paraesthesia
More
|
On the afternoon of 5/8/2025, patient developed soreness at site of injections. Took Ibuprofen. The ...
On the afternoon of 5/8/2025, patient developed soreness at site of injections. Took Ibuprofen. The next morning she noticed tingling in RT hand and distal half of forearm when lifting hand toward face, noticed when applying make up. Still with pain at injection site and noticed mild redness and swelling. On exam she has 2cm x 2cm erythema and mild edema of RT deltoid area. RT hand and arm has good strength and tone and sensation intact.
More
|
||||||
| 2840503 | 62 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
FDP00015 |
No adverse event
No adverse event
|
The treatment was the second dose of a two-series vaccination; the outcome was uneventful, with no s...
The treatment was the second dose of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reactions reported.
More
|
||||||
| 2840504 | 51 | M | CA | 05/12/2025 |
FLU3 |
SEQIRUS, INC. |
AW3225B |
Arthralgia, Asthenia, Sleep disorder
Arthralgia, Asthenia, Sleep disorder
|
Severe pain in shoulder causing lack of sleep and loss of strength in arm. Patient has not slept a ...
Severe pain in shoulder causing lack of sleep and loss of strength in arm. Patient has not slept a full night's sleep since pain began in November 2024.
More
|
โ | |||||
| 2840505 | 0.25 | M | NC | 05/12/2025 |
RV1 |
GLAXOSMITHKLINE BIOLOGICALS |
7E9X2 |
Vomiting projectile
Vomiting projectile
|
Projectile Vomiting x3
Projectile Vomiting x3
|
||||||
| 2840506 | 65 | F | NJ | 05/12/2025 |
PNC21 |
MERCK & CO. INC. |
Y013009 |
Erythema, Pain
Erythema, Pain
|
Redness and soreness around the area
Redness and soreness around the area
|
||||||
| 2840507 | 65 | F | PA | 05/12/2025 |
COVID19 COVID19 TDAP TDAP |
MODERNA MODERNA GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
3046731 3046731 DY3K7 DY3K7 |
Fatigue, Hypersensitivity, Inflammation, Injection site erythema, Injection site...
Fatigue, Hypersensitivity, Inflammation, Injection site erythema, Injection site pain; Injection site pruritus, Malaise, Pyrexia; Fatigue, Hypersensitivity, Inflammation, Injection site erythema, Injection site pain; Injection site pruritus, Malaise, Pyrexia
More
|
Documentation copied from provider's office visit note today (5/12/25): "Patient is a 65 ...
Documentation copied from provider's office visit note today (5/12/25): "Patient is a 65 y.o. female who presents today to walk-in clinic regarding vaccine reaction. Had tetanus and COVID vaccines on Friday (5/9/25). Afterwards, was not feeling well. Was fatigued, had fever 100.8 over the weekend. Was taking Benadryl and Tylenol over the weekend. Has noticed redness at injection sites on both her arms. Describes the areas as intermittently painful and pruritic. Was advised not to get her routine allergy shot today due to the symptoms. Her next shot is tomorrow, and following one will be Friday. Suspect patient's symptoms are due to recent vaccination injections. Notably, injections were administered to the mid-upper arm bilaterally, rather than higher in the deltoid. Suspect inflammatory and/or allergic reaction. Advised to continue with Zyrtec or Benadryl, Tylenol as needed for pain control, local ice/cold compresses to reduce inflammation. Cannot take NSAIDs due to prior stroke. Follow up if symptoms worsen or persist. Skin Comments: Erythematous macular region present on bilateral upper arms, at sites of previous injections."
More
|
||||||
| 2840508 | 16 | M | NE | 05/12/2025 |
HEP |
DYNAVAX TECHNOLOGIES CORPORATION |
945664 |
No adverse event, Product administered to patient of inappropriate age
No adverse event, Product administered to patient of inappropriate age
|
Patient is 16 years old. Was given Heplisav B which is indicated for patients 18 years and older. Di...
Patient is 16 years old. Was given Heplisav B which is indicated for patients 18 years and older. Did not experience any adverse event or side effects per mother.
More
|
||||||
| 2840509 | 12 | M | CA | 05/12/2025 |
HPV9 HPV9 MNQ MNQ TDAP TDAP HPV9 HPV9 MNQ MNQ TDAP TDAP |
MERCK & CO. INC. MERCK & CO. INC. NOVARTIS VACCINES AND DIAGNOSTICS NOVARTIS VACCINES AND DIAGNOSTICS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS MERCK & CO. INC. MERCK & CO. INC. NOVARTIS VACCINES AND DIAGNOSTICS NOVARTIS VACCINES AND DIAGNOSTICS GLAXOSMITHKLINE BIOLOGICALS GLAXOSMITHKLINE BIOLOGICALS |
Y014510 Y014510 FX3ED FX3ED 4RF9D 4RF9D Y024510 Y024510 FX3ED FX3ED 4RF9D 4RF9D |
Erythema, Eye pruritus, Rash; Erythema, Eye pruritus, Rash, Swelling face; Eryth...
Erythema, Eye pruritus, Rash; Erythema, Eye pruritus, Rash, Swelling face; Erythema, Eye pruritus, Rash; Erythema, Eye pruritus, Rash, Swelling face; Erythema, Eye pruritus, Rash; Erythema, Eye pruritus, Rash, Swelling face; Erythema, Eye pruritus, Rash; Erythema, Eye pruritus, Rash, Swelling face; Erythema, Eye pruritus, Rash; Erythema, Eye pruritus, Rash, Swelling face; Erythema, Eye pruritus, Rash; Erythema, Eye pruritus, Rash, Swelling face
More
|
The patient presented to the clinic for routine vaccinations, including TDaP, meningococcal, and HPV...
The patient presented to the clinic for routine vaccinations, including TDaP, meningococcal, and HPV immunizations. The vaccines were administered successfully, and the patient was monitored for 15 minutes with no adverse reactions observed. Approximately 80 minutes later, the mother returned with her son, who exhibited a mild rash on the jaw extending to the neck and partially to the cheeks bilaterally. After five minutes, the patient developed facial redness and reported itching of the eyes. The patient was evaluated promptly, and appropriate treatment was administered, including intramuscular epinephrine (0.3 mg/mL) and 25 mg of diphenhydramine (Benadryl) The patient presented to the clinic for routine vaccinations, including TDaP, meningococcal, and HPV immunizations. The vaccines were administered successfully, and the patient was monitored for 15 minutes with no adverse reactions observed. Approximately 80 minutes later, the mother returned with her son, who exhibited a mild rash on the jaw extending to the neck and partially to the cheeks bilaterally. After five minutes, the patient developed facial redness and reported itching of the eyes. The patient was evaluated promptly, and appropriate treatment was administered, including intramuscular epinephrine (0.3 mg/mL) and 25 mg of diphenhydramine (Benadryl)The patient presented to the clinic for routine vaccinations, including TDaP, meningococcal, and HPV immunizations. The vaccines were administered successfully, and the patient was monitored for 15 minutes with no adverse reactions observed. Approximately 80 minutes later, the mother returned with her son, who exhibited a mild rash on the jaw extending to the neck and partially to the cheeks bilaterally. After five minutes, the patient developed facial redness and reported itching of the eyes. The patient was evaluated promptly, and appropriate treatment was administered, including intramuscular epinephrine (0.3 mg/mL) and 25 mg of diphenhydramine (Benadryl)The patient presented to the clinic for routine vaccinations, including TDaP, meningococcal, and HPV immunizations. The vaccines were administered successfully, and the patient was monitored for 15 minutes with no adverse reactions observed. Approximately 80 minutes later, the mother returned with her son, who exhibited a mild rash on the jaw extending to the neck and partially to the cheeks bilaterally. After five minutes, the patient developed facial redness and reported itching of the eyes. The patient was evaluated promptly, and appropriate treatment was administered, including intramuscular epinephrine (0.3 mg/mL) and 25 mg of diphenhydramine (Benadryl) The rash and facial redness resolved shortly after treatment..
More
|
||||||
| 2840510 | 39 | F | NM | 05/12/2025 |
HPV9 |
MERCK & CO. INC. |
y010656 |
Rash, Rash erythematous
Rash, Rash erythematous
|
red bumpy rash starting at inside of elbow and extending to top of hand, seems to be getting worse. ...
red bumpy rash starting at inside of elbow and extending to top of hand, seems to be getting worse. has tried hydrocortisone cream with no relieve, has also tried eczema cream.
More
|
||||||
| 2840511 | 35 | M | OR | 05/12/2025 |
COVID19 |
PFIZER\BIONTECH |
MD3414 |
Rash, Rash pruritic, Rash vesicular
Rash, Rash pruritic, Rash vesicular
|
Patient reported having fluid filled bumps that are itchy, patient declined any shortness of breath,...
Patient reported having fluid filled bumps that are itchy, patient declined any shortness of breath, tightness in the throat or difficulty breathing, stated that bumps are all over his body and that steroid cream is not helpful in getting rid of them but do help with the itching. Patient was advised to take Benadryl, and to follow up if symptoms did not resolve in a week, or if new symptoms arised.
More
|
||||||
| 2840512 | 43 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
FDP00015 |
No adverse event
No adverse event
|
The treatment was the second of a two-series vaccination. The outcome was uneventful, with no sympto...
The treatment was the second of a two-series vaccination. The outcome was uneventful, with no symptoms or signs of reaction reported.
More
|
||||||
| 2840513 | 45 | M | WA | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
96868 |
Incorrect route of product administration, No adverse event
Incorrect route of product administration, No adverse event
|
Dose was accidentally administered IM versus subq. Patient stayed in clinic for 15 minutes following...
Dose was accidentally administered IM versus subq. Patient stayed in clinic for 15 minutes following immunization reporting no adverse symptoms at this time. Encouraged patient to reach out with current questions or concerns. Charge notified.
More
|
||||||
| 2840514 | 35 | M | AZ | 05/12/2025 |
SMALLMNK VARZOS |
BAVARIAN NORDIC GLAXOSMITHKLINE BIOLOGICALS |
FDP00016 E7335 |
No adverse event; No adverse event
No adverse event; No adverse event
|
Treatment was first of a two-series vaccination; the outcome was uneventful, with no symptoms or sig...
Treatment was first of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reaction reported.
More
|
||||||
| 2840515 | 60 | F | VA | 05/12/2025 |
RSV |
GLAXOSMITHKLINE BIOLOGICALS |
4B22T |
No adverse event
No adverse event
|
No Adverse even
No Adverse even
|
||||||
| 2840516 | 44 | F | CA | 05/12/2025 |
TDAP |
GLAXOSMITHKLINE BIOLOGICALS |
PG3RP |
Paraesthesia, Peripheral swelling
Paraesthesia, Peripheral swelling
|
12-18 Hours following the vaccine, tingling and swelling in both hands and arms began. It has conti...
12-18 Hours following the vaccine, tingling and swelling in both hands and arms began. It has continued until this date (9 days post-vaccine) even with anti-inflammatories (Naproxen) and compression gloves.
More
|
||||||
| 2840517 | 31 | M | AZ | 05/12/2025 |
SMALLMNK |
BAVARIAN NORDIC |
FDP00016 |
No adverse event
No adverse event
|
The treatment was the second of a two-series vaccination; the outcome was uneventful, with no sympto...
The treatment was the second of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reactions reported.
More
|
||||||
| 2840518 | 54 | M | AZ | 05/12/2025 |
PNC20 SMALLMNK |
PFIZER\WYETH BAVARIAN NORDIC |
LK6650 96867 |
No adverse event; No adverse event
No adverse event; No adverse event
|
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptom...
The treatment was the first of a two-series vaccination; the outcome was uneventful, with no symptoms or signs of reactions reported.
More
|